Assessment of invasion in lung adenocarcinoma classification, including adenocarcinoma in situ and minimally invasive adenocarcinoma

被引:38
|
作者
Borczuk, Alain C. [1 ]
机构
[1] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10032 USA
关键词
adenocarcinoma in situ; invasion; lung adenocarcinoma; GROUND-GLASS OPACITY; PROGNOSTIC-SIGNIFICANCE; MICROPAPILLARY PATTERN; INTERNATIONAL-ASSOCIATION; CANCER; FEATURES; GRADE; MUTATIONS; GEFITINIB; CARCINOMA;
D O I
10.1038/modpathol.2011.151
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Classification of adenocarcinoma has undergone recent evaluation to better align histological classification with clinical outcomes. One terminology, in particular, that of bronchioloalveolar carcinoma (BAC), has been debated for many decades. Although initial discussion surrounded the cell-of-origin of this tumor, more recent confusion has been generated from the use of this term both as a pattern of growth within an otherwise invasive adenocarcinoma and as a term for a pre-invasive tumor synonymous with adenocarcinoma in situ. As a result, adenocarcinomas with quite different radiology, gross morphology and metastatic potential have been associated with the BAC term. Focusing on invasion and using an illustrative case, we will explore the current recommendations that incorporate assessment of invasion to clarify the confusion caused by the different uses of the historical term 'BAC'. Modern Pathology (2012) 25, S1-S10; doi:10.1038/modpathol.2011.151
引用
收藏
页码:S1 / S10
页数:10
相关论文
共 50 条
  • [1] EGFR Mutations Promote Lung Adenocarcinoma From Adenocarcinoma in Situ to Minimally Invasive Carcinoma to Invasive Adenocarcinoma
    Zhu, J.
    Ma, Y.
    Wang, H.
    Jiang, T.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S208 - S208
  • [2] Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung
    Naito, Masahito
    Aokage, Keiju
    Saruwatari, Kouichi
    Hisakane, Kakeru
    Miyoshi, Tomohiro
    Hishida, Tomoyuki
    Yoshida, Junji
    Masato, Sugano
    Kojima, Motohiro
    Kuwata, Takeshi
    Fujii, Satoshi
    Ochiai, Atsushi
    Sato, Yukitoshi
    Tsuboi, Masahiro
    Ishii, Genichiro
    LUNG CANCER, 2016, 100 : 53 - 62
  • [3] Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma
    Behera, Madhusmita
    Owonikoko, Taofeek K.
    Gal, Anthony A.
    Steuer, Conor E.
    Kim, Sungjin
    Pillai, Rathi N.
    Khuri, Fadlo R.
    Ramalingam, Suresh S.
    Sica, Gabriel L.
    CLINICAL LUNG CANCER, 2016, 17 (05) : E57 - E64
  • [4] Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma
    Weichert, Wilko
    Warth, Arne
    CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (04) : 309 - 316
  • [5] Discriminating between bronchiolar adenoma, adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung with CT
    Cao, L.
    Wang, Z.
    Gong, T.
    Wang, J.
    Liu, J.
    Jin, L.
    Yuan, Q.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2020, 101 (12) : 831 - 837
  • [6] Long-term Postoperative Prognosis of Adenocarcinoma in Situ and Minimally Invasive Adenocarcinoma of Lung
    Yotsukura, M.
    Motoi, N.
    Yoshida, Y.
    Nakagawa, K.
    Yatabe, Y.
    Watanabe, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S263 - S263
  • [7] Distinctive clinicopathological features of adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: A retrospective study
    Ishida, Hironori
    Shimizu, Yoshihiko
    Sakaguchi, Hirozo
    Nitanda, Hiroyuki
    Kaneko, Koichi
    Yamazaki, Nobuhiro
    Yanagihara, Akitoshi
    Taguchi, Ryo
    Sakai, Fumikazu
    Yasuda, Masanori
    Kobayashi, Kunihiko
    LUNG CANCER, 2019, 129 : 16 - 21
  • [8] Defining Invasion in Minimally Invasive Adenocarcinoma
    Noguchi, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S258 - S259
  • [9] Mutational distinction between adenocarcinoma in situ, minimally invasive adenocarcinoma and invasive adenocarcinoma in lung cancer patients with multiple tumors.
    Liu, Jixian
    Li, Yingmei
    Xie, Yuancai
    Luan, Xinyu
    Peng, Xuxing
    Mu, Tianhao
    Chen, Shifu
    Wu, Da
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Lung Adenocarcinoma Staging Based on 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ (AIS) and Minimally Invasive Adenocarcinoma (MIA)
    Behera, M.
    Steuer, C.
    Gal, A.
    Owonikoko, T.
    Khuri, F.
    Ramalingam, S.
    Sica, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S10 - S10